Trials / Completed
CompletedNCT06789185
Effects of Esketamine at Subanesthetic Dose on Emergence Delirium in Preschool Children Undergoing Ambulatory Laparoscopic Surgery
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 96 (actual)
- Sponsor
- Qiu jinpeng · Academic / Other
- Sex
- All
- Age
- 24 Months – 71 Months
- Healthy volunteers
- Not accepted
Summary
Emergence delirium (ED) is a manifestation of acute postoperative brain dysfunction that occurs with a relatively high frequency after pediatric anesthesia. The incidence varies depending on the diagnostic criteria used and the combination of administered anesthetic drugs. The goal of this clinical trial is to investigate whether a subanesthetic dose of esketamine can reduce incidence of ED.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 0.1mg/kg esketamine | Intravenous injection 0.1mg/kg esketamine about 5min before the end of the surgery |
| DRUG | 0.2mg/kg esketamine | Intravenous injection 0.2mg/kg esketamine about 5min before the end of the surgery |
| DRUG | 0.1ml/kg normal saline | Intravenous injection 0.1ml/kg normal saline about 5min before the end of the surgery |
Timeline
- Start date
- 2025-02-07
- Primary completion
- 2025-05-16
- Completion
- 2025-05-16
- First posted
- 2025-01-23
- Last updated
- 2025-05-22
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06789185. Inclusion in this directory is not an endorsement.